Company: IOBT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001193125-25-180860
Chunk: 1

Company: IO Biotech, Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Item 1
Chunk 1
---
 June 30, 2025 and December 31, 2024, respectively

     66

     66

     Additional paid-in capital

     416,289

     413,113

     Accumulated deficit

     (407,951
     )

     (359,313
     )

     Accumulated other comprehensive loss

     (6,812
     )

     (6,851
     )

     Total stockholders’ equity

     1,592

     47,015

     Total liabilities and stockholders’ equity
      
     $
     42,326

     $
     67,699

See accompanying notes to the unaudited interim consolidated financial statements.